| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/25/2013 | US20130190290 Substituted phenylimidazopyrazoles and their use |
| 07/25/2013 | US20130190286 B-raf kinase inhibitors |
| 07/25/2013 | US20130190281 Compositions Containing Satiogens and Methods of Use |
| 07/25/2013 | US20130190278 Compounds for the Treatment/Prevention of Ocular Inflammatory Diseases |
| 07/25/2013 | US20130190276 Use of 5-h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 07/25/2013 | US20130190275 Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders |
| 07/25/2013 | US20130190267 Polysaccharide-based polymer tissue adhesive for medical use |
| 07/25/2013 | US20130190258 Compounds for inhibition of cancer cell proliferation |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130190249 Therapeutically active compositions and their methods of use |
| 07/25/2013 | US20130190238 Treatments for Gastrointestinal Disorders |
| 07/25/2013 | US20130190234 The use of alkylated semi-synthetic glycosaminoglycosan ethers for the treatment of dental disorders |
| 07/25/2013 | US20130190233 Peptides, derivatives and analogs thereof, and methods of using same |
| 07/25/2013 | US20130190230 Compositions and methods for treating cognitive deficits |
| 07/25/2013 | US20130190227 Chitosan derivatives to treat animals or optimize animal health |
| 07/25/2013 | US20130190225 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment |
| 07/25/2013 | US20130189678 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/25/2013 | US20130189382 Use of fucoxanthin in the preparation of product for improving memory and having neuroprotective effect associated with neurodegenerative disorder |
| 07/25/2013 | US20130189317 Novel dosage and formulation |
| 07/25/2013 | US20130189307 Method of treating depression |
| 07/25/2013 | US20130189285 Antibodies against ramp3 |
| 07/25/2013 | US20130189274 Phosphatidylinositol-3-kinase pathway biomarkers |
| 07/25/2013 | US20130189262 IL-27 Antagonists for Treating Inflammatory Diseases |
| 07/25/2013 | US20130189255 Fusions and conjugates of insulinotropic agents |
| 07/25/2013 | US20130189251 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 07/25/2013 | US20130189249 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| 07/25/2013 | US20130189246 Treatment of ophthalmic conditions with fluorenone derivatives |
| 07/25/2013 | US20130189242 Hyaluronidase and Method of use Thereof |
| 07/25/2013 | US20130189237 Co-enzyme q10 formulations and methods of use |
| 07/25/2013 | US20130189235 Methods of treating spinal cord injury and minimizing scarring |
| 07/25/2013 | US20130189224 Compositions, methods, and kits for eliciting an immune response |
| 07/25/2013 | US20130189221 Polysaccharide-based polymer tissue adhesive for medical use |
| 07/25/2013 | US20130189215 Polyimidazoles for use as bile acid sequestrants |
| 07/25/2013 | US20130186829 Buffered compositions for dialysis |
| 07/25/2013 | US20130186801 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/24/2013 | EP2618147A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention |
| 07/24/2013 | EP2617435A1 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants |
| 07/24/2013 | EP2617421A1 Tetrahydrofolates in combination with EGFR-inhibitors in the use of treating cancer |
| 07/24/2013 | EP2617414A2 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/24/2013 | EP2616083A2 Removal of toxins from gastrointestinal fluids |
| 07/24/2013 | EP2616075A1 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
| 07/24/2013 | EP2616063A1 Hsp90 inhibitors for treating non-small cell lung cancers in wild-type egfr and/or kras patients |
| 07/24/2013 | EP2616048A1 Preparation and use of combination enzyme and gastrointestinal modulator delivery systems |
| 07/24/2013 | CN1984664B Methods for treating bleeding disorders using sulfated polysaccharides |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN1462191B Treatment of ocute coronary syndrome with GLP-1 |
| 07/24/2013 | CN103221066A Sustained-release pharmaceutical composition |
| 07/24/2013 | CN103215351A In vitro cancer therapy compound identification method |
| 07/24/2013 | CN103212093A Magnetic nano-grade material with cell-targeting property, and biomedical application thereof |
| 07/24/2013 | CN103212079A Oral medical composition for preventing and/or treating cold and application thereof |
| 07/24/2013 | CN103212078A Combinations comprising mglur modulators for the treatment of parkinson's disease |
| 07/24/2013 | CN103212077A Application of Erbin inhibitor in preparation of antitumor drug |
| 07/24/2013 | CN103212076A Compositions comprising ceftaroline and methods of treatment |
| 07/24/2013 | CN103212075A Eye drop containing VEGF antagonist |
| 07/24/2013 | CN103212064A Application of phosphorylation-pathway-related factor in regulating regulatory T-cell function |
| 07/24/2013 | CN102698274B Medicine composition for treating intractable escherichia coli of fowls |
| 07/24/2013 | CN102580093B Injection for preventing piglet diseases and preparation method thereof |
| 07/24/2013 | CN102159245B Combination of hcv ns3 protease inhibitor with interferon and ribavirin |
| 07/24/2013 | CN101652147B Combined use of dipeptidyl peptidase IV inhibitor compound and sweetener |
| 07/24/2013 | CN101391103B Medicine composition for preventing and treating AIDS viral infection |
| 07/23/2013 | US8492406 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 07/23/2013 | US8492081 Aldehyde-fixed, dried platelets with covalently attached exogenous active agent and method of making thereof |
| 07/23/2013 | US8491904 Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography |
| 07/23/2013 | US8491902 Medicament comprising recombinant antibody against chemokine receptor CCR4 |
| 07/23/2013 | US8491882 Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2569072C Preparation for localized delivery of therapeutic agent |
| 07/23/2013 | CA2471968C Immunostimulatory nucleic acids and use thereof |
| 07/23/2013 | CA2432644C Pharmaceutical composition comprising aspirintm and cs-747 |
| 07/18/2013 | WO2013106702A1 Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
| 07/18/2013 | WO2013106520A1 Hepatitis c virus inhibitors |
| 07/18/2013 | WO2013106175A1 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof |
| 07/18/2013 | WO2013105417A1 Biochemical evaluation method |
| 07/18/2013 | WO2013105092A1 Fixed dose combination therapy of parkinson's disease |
| 07/18/2013 | WO2013105088A1 Combination therapy for the treatment of cancer |
| 07/18/2013 | WO2013104871A1 Composition containing agmatine, and uses thereof in preparing drugs or neutraceutical substances |
| 07/18/2013 | WO2013037943A8 Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors |
| 07/18/2013 | US20130184519 Cardiac support device with differential compliance |
| 07/18/2013 | US20130184345 Oligo-benzamide compounds for use in treating cancers |
| 07/18/2013 | US20130184344 Levodopa prodrug mesylate hydrate |
| 07/18/2013 | US20130184340 Anti-cancer compositions and methods |
| 07/18/2013 | US20130184339 Anti-cancer compositions and methods |
| 07/18/2013 | US20130184337 Sodium ascorbate stimulation of elastogenesis |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184311 Crystalline forms of the sodium salt of (4--cyclohexyl)-acetic acid |
| 07/18/2013 | US20130184297 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/18/2013 | US20130184294 Pyrimidones for Treatment of Potassium Channel Related Diseases |
| 07/18/2013 | US20130184287 Indazole compounds and their uses |
| 07/18/2013 | US20130184284 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184282 Ip receptor agonist heterocyclic compounds |
| 07/18/2013 | US20130184273 Bicyclic pyrimidines |
| 07/18/2013 | US20130184263 Derivatives of Betulin |
| 07/18/2013 | US20130184262 Diaminocyclohexane compounds and uses thereof |
| 07/18/2013 | US20130184260 Pyridazinone derivatives |
| 07/18/2013 | US20130184247 Method for preparation of nicotinic acid copper chloride complex, and its pharmaceutical uses |
| 07/18/2013 | US20130184243 Compositions of alkylating agents and methods of treating skin disorders therewith |
| 07/18/2013 | US20130184242 Pharmaceutical Composition for Topical Application |
| 07/18/2013 | US20130184239 Combination of siloxane and active ingredient for treating dental disorder |
| 07/18/2013 | US20130184235 Hyaluronic acid derivatives containing groups able to release no |
| 07/18/2013 | US20130184234 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |